Patent Lawyer Benjamin Pelletier Joins Haynes and Boone’s Precision Medicine and Digital Health Practice

01/25/2021

Benjamin Pelletier, a patent lawyer with a strong focus on the biotech, pharmaceutical, life science, and medical device industries, has joined Haynes and Boone, LLP’s growing Precision Medicine and Digital Health Practice Group in the San Francisco office.

A former biochemical engineer, Ben has spent much of his legal career advising clients in the complex and fast-evolving areas of biology, medicine, engineering, and data science. He has significant experience building patent portfolios relating to monoclonal antibodies and antibody-drug conjugates (ADCs), CAR-T cells, stem cells, tissue engineering, 3D bioprinting, biosensors, genomic sequencing, and bioinformatics, as well as companion diagnostic assay systems and devices.

He has helped many clients develop and protect their intellectual property in the immuno-oncology space, with a particular focus on cellular therapeutics, bispecific T-cell engagers (TCEs) and other large molecule compositions.

“Ben has an impressive background and deep understanding of technology and bioengineering. He brings a wealth of knowledge and added strength to the team,” said Partner Roger Kuan, chair of Haynes and Boone’s Precision Medicine and Digital Health Practice Group. “Ben can help advise clients in any aspect of our current practice and expands our capabilities to now include large molecule therapeutics, biologics manufacturing and cell therapies.”

Ben most recently worked as a partner in the Patent Prosecution and Counseling Practice at a San Francisco firm. He will work in Haynes and Boone’s newest office, on Spear Street, where he joins Kuan and Partner Jason Novak and other professionals who helped create and grow the Precision Medicine and Digital Health Practice Group in 2020.

Ben said he was drawn to Haynes and Boone because of its growing precision medicine practice and its strong synergy with many of his clients in the industry.

“My practice meshes very well with the background and experience of the other lawyers in the group. I look forward to working with my new colleagues to help our clients in the biotech sector,” he said.

Ben holds an advanced degree in bioengineering and spent many years working as an engineer and project manager at a leading biotechnology company. He was named a Super Lawyers Rising Star in Northern California (2019-2020) and listed in Legal 500 for IP – Patents: Prosecution (including re-examination and post-grant proceedings) in 2019.

Haynes and Boone’s Precision Medicine and Digital Health Practice Group provides full-service counsel to the key players in precision medicine and digital health – from technology startups to established corporations, non-profit research institutions, universities, hospital systems, pharmaceuticals, and investors supporting the industry. Lawyers on the team draw on the firm’s highly regarded healthcare, life sciences, technology and IP experience to address trends in evolving markets, cutting-edge advances in technology, and legal and regulatory changes.

Haynes and Boone is an international corporate law firm with offices in Texas, New York, California, Charlotte, Chicago, Denver, Washington, D.C., London, Mexico City and Shanghai, providing a full spectrum of legal services in energy, technology, financial services and private equity. With more than 575 lawyers, Haynes and Boone is ranked among the largest U.S.-based firms by The National Law Journal, The American Lawyer and The Lawyer. It also was recognized across the board for excellence in the BTI Consulting Group’s 2020 “A-Team” report, which identifies the law firms that in-house counsel commends for providing superior client service.

The following publications reported on Ben's move to the firm:

Bloomberg Law

Daily Journal

Thomas Reuters Westlaw

Media Contact

Nathan Koppel
Director of Media Relations
+1 512.867.8431
nathan.koppel@haynesboone.com

Email Disclaimer